Increased Surveillance Recommended for Children at Risk for Hematopoietic Malignancy Predisposition
Scientists find core regulatory circuit controlling identity of aggressive lymphoma
Bortezomib extends survival of children with newly diagnosed T-cell lymphoblastic lymphoma
Researchers Identify RAD21 Variants in Pediatric Lymphoblastic Leukemia or Lymphoma
Bortezomib Improves Survival in Children with Newly Diagnosed T-Cell Lymphoblastic Lymphoma
Yale-led studies open doors for treatment of lymphoma and neuroblastoma cancers
FDA Approves Rylaze as Alternative for Patients with ALL and Lymphoblastic Lymphoma
Long-Term Survivors of Childhood Hodgkin Lymphoma at Increased Risk for Neurocognitive Impairment
Rituximab Regimen Improves Survival in Children With Aggressive B-Cell Lymphoma
A new immunotherapeutic agent for children and adolescents with advanced lymphoma